|Articles|July 1, 2019 (Updated: November 15, 2020)
- Pharmaceutical Executive-07-01-2019
- Volume 39
- Issue 7
Pharmaceutical Executive, July 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Creating an ‘Unbossed’ Environment in the Workplaceover 6 years ago
Proposed Rebates Rule Raises Tough Questionsover 6 years ago
Drug Formulary Decisions: Fixing a Broken Systemover 6 years ago
The Feasibility of Patient Insights Before Launchover 6 years ago
Compliance Disruptorsover 6 years ago
Asia’s Complex Compliance Landscapeover 6 years ago
European Pricing Talks: A lot of Smoke—or is it Fire?over 6 years ago
FDA Maps Pathway to More Accessible Biosimilarsover 6 years ago
Top Trends, Takeaways from DIAover 6 years ago
Pharma & Biotech: Financial Pulse-Check, OutlookNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5